Literature DB >> 24608303

Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.

Kinuko Nagayoshi1, Takashi Ueki, Yasunobu Nishioka, Tatsuya Manabe, Yusuke Mizuuchi, Minako Hirahashi, Yoshinao Oda, Masao Tanaka.   

Abstract

BACKGROUND: Extranodal tumor deposits are involved in TNM classification. However, it is uncertain whether a tumor deposit is a regular lymph node metastasis, and its prognostic significance in patients with stage II or III colorectal cancer remains to be established.
OBJECTIVE: This study aimed to determine the prognostic significance of tumor deposits for stage II and III colorectal cancer.
DESIGN: This study is a retrospective review of clinicopathological data.
SETTING: This study was conducted at a tertiary care hospital/referral center in Japan. PATIENTS: We reviewed the clinical course of 171 stage II and 173 stage III consecutive patients between January 1999 and December 2006. MAIN OUTCOME MEASURES: We examined the clinicopathological features of colorectal cancers with tumor deposits and calculated overall survival and recurrence-free survival of the patients according to the status of tumor deposits. The primary outcome was the impact of tumor deposits on patient survival.
RESULTS: Thirty-five (10.2%) patients with colorectal cancers had tumor deposits in the pericolic and/or mesocolic region. Survival rates among the patients with tumor deposits were significantly lower than those without (5-year overall survival: 58.4% vs 81.0%, p < 0.0001; 5-year recurrence-free survival: 47.1% vs 73.4%, p < 0.0001). Tumor deposit was an independent prognostic factor for patients with colorectal cancer in multivariate analysis (overall survival: HR, 2.30; 95% CI, 1.26-4.04; p = 0.04; recurrence-free survival: HR, 2.42; 95% CI, 1.04-4.90; p = 0.04). Tumor deposit was an independent prognostic factor in N0 and N1 colorectal cancer, whereas N2 cancer had poor survival outcome regardless of tumor deposit. LIMITATIONS: Our study was a single-institution retrospective study, and the numbers of patients were relatively small to draw firm conclusions.
CONCLUSION: Tumor deposit may be an independent adverse prognostic factor for stage II and III N1 colorectal cancer.

Entities:  

Mesh:

Year:  2014        PMID: 24608303     DOI: 10.1097/DCR.0000000000000059

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  22 in total

1.  Comparison of model fit and discriminatory ability of the 8th edition of the tumor-node-metastasis classification and the 9th edition of the Japanese classification to identify stage III colorectal cancer.

Authors:  Kei Kitamura; Dai Shida; Shigeki Sekine; Yuka Ahiko; Yuya Nakamura; Konosuke Moritani; Shunsuke Tsukamoto; Yukihide Kanemitsu
Journal:  Int J Clin Oncol       Date:  2021-06-03       Impact factor: 3.402

Review 2.  Management of nodal disease from colon cancer in the laparoscopic era.

Authors:  Corrado Pedrazzani; Lelde Lauka; Simone Sforza; Andrea Ruzzenente; Filippo Nifosì; GianGaetano Delaini; Alfredo Guglielmi
Journal:  Int J Colorectal Dis       Date:  2014-11-22       Impact factor: 2.571

3.  Utility of texture analysis on T2-weighted MR for differentiating tumor deposits from mesorectal nodes in rectal cancer patients, in a retrospective cohort.

Authors:  Isha D Atre; Kulyada Eurboonyanun; Yoshifumi Noda; Anushri Parakh; Aileen O'Shea; Rita Maria Lahoud; Naomi M Sell; Hiroko Kunitake; Mukesh G Harisinghani
Journal:  Abdom Radiol (NY)       Date:  2020-07-22

4.  Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score-matched analysis.

Authors:  Wenyuan Ye; Liming Shi; Liwen Qian; Yikan Sun; Xiaonan Sun
Journal:  Cancer Rep (Hoboken)       Date:  2019-06-02

5.  Prognostic value of tumor deposits for long-term oncologic outcomes in patients with stage III colorectal cancer: a systematic review and meta-analysis.

Authors:  Jae Young Moon; Min Ro Lee; Gi Won Ha
Journal:  Int J Colorectal Dis       Date:  2021-10-01       Impact factor: 2.571

6.  Association of KRAS mutation with tumor deposit status and overall survival of colorectal cancer.

Authors:  Meifang Zhang; Wenwei Hu; Kun Hu; Yong Lin; Zhaohui Feng; Jing-Ping Yun; Nan Gao; Lanjing Zhang
Journal:  Cancer Causes Control       Date:  2020-05-11       Impact factor: 2.506

7.  The impact of tumor deposits on colonic adenocarcinoma AJCC TNM staging and outcome.

Authors:  Ming Jin; Rachel Roth; Jonathan B Rock; Mary Kay Washington; Amy Lehman; Wendy L Frankel
Journal:  Am J Surg Pathol       Date:  2015-01       Impact factor: 6.394

8.  Tumor deposit is a poor prognostic indicator in patients who underwent simultaneous resection for synchronous colorectal liver metastases.

Authors:  Qi Lin; Ye Wei; Li Ren; Yunshi Zhong; Chunzhi Qin; Peng Zheng; Pingping Xu; Dexiang Zhu; Meiling Ji; Jianmin Xu
Journal:  Onco Targets Ther       Date:  2015-01-22       Impact factor: 4.147

9.  Time-dependent and nonlinear effects of prognostic factors in nonmetastatic colorectal cancer.

Authors:  Sheng-Qiang Chi; Yu Tian; Jun Li; Dan-Yang Tong; Xiang-Xing Kong; Graeme Poston; Ke-Feng Ding; Jing-Song Li
Journal:  Cancer Med       Date:  2017-07-14       Impact factor: 4.452

10.  The unique prognostic characteristics of tumor deposits in colorectal cancer patients.

Authors:  Fangqi Liu; Jiang Zhao; Cong Li; Yuchen Wu; Wang Song; Tianan Guo; Shiqing Chen; Sanjun Cai; Dan Huang; Ye Xu
Journal:  Ann Transl Med       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.